Mayne Pharma Group Ltd Long-term Investment Intensity
Mayne Pharma Group Ltd long-term investment intensity. Mayne Pharma Group Ltd (MYX) has a Long-term Investment Intensity of 1.3% as of June 2024. Long-term investments of AU$15.34 Million represent 1.3% of total assets of AU$1.14 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See MYX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Mayne Pharma Group Ltd (2014–2024)
Long-term investment intensity of Mayne Pharma Group Ltd from 2014 to 2024. This chart shows how Mayne Pharma Group Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2014 to 2024. As of June 2024, the intensity stands at 1.3%, reflecting long-term investments of AU$15.34 Million against total assets of AU$1.14 Billion AUD. See operational self-sufficiency of Mayne Pharma Group Ltd to measure how many days the company can operate on defensive assets alone.
Mayne Pharma Group Ltd Long-term Investment Intensity by Year (2014–2024)
Mayne Pharma Group Ltd long-term investment intensity by year from 2014 to 2024. The table below presents the year-by-year Long-term Investment Intensity for Mayne Pharma Group Ltd from 2014 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MYX current and non-current assets.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 1.3% | AU$15.34 Million | AU$1.14 Billion | ▼ -0.2 pp |
| 2014 | 1.5% | AU$4.08 Million | AU$265.82 Million | — |